Advancing the Integration of ‘Basic/Fundamental’ and Translational Cellular and Gene Therapy Science within the EBMT: Accelerating the Pathway to Progress
Bone Marrow Transplant. 2025 Aug 7. doi: 10.1038/s41409-025-02688-x.…
White paper on best practices for translational research in neuroendocrine neoplasms
J Neuroendocrinol. 2025 Jul 28:e70072. doi: 10.1111/jne.70072.…
The STAT3/TIMP1 inhibitor silibinin overcomes secondary immunoresistance to pembrolizumab in brain metastases from METex14 skipping mutated non-small cell lung cancer: a case report
Front Med (Lausanne). 2025 Jul 9;12:1612327. doi: 10.3389/fmed.2025.1612327.…
Final overall survival and safety analyses of the phase 3 PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer
Ann Oncol. 2025 Jul 16:S0923-7534(25)00852-X. doi: 10.1016/j.annonc.2025.07.003.…
Humanized mouse models in MDS
Cell Death Dis. 2025 Jul 17;16(1):531. doi: 10.1038/s41419-025-07861-0.ABSTRACTMyelodysplastic…
Anomalies on anterior and posterior complex views in fetuses with partial agenesis of corpus callosum
Ultrasound Obstet Gynecol. 2025 Jul 11. doi: 10.1002/uog.29292.…
Metabolic hallmarks of trastuzumab resistance
Expert Opin Ther Targets. 2025 Jul 11. doi: 10.1080/14728222.2025.2532394.…
Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations
Eur J Cancer. 2025 Jun 24;226:115591. doi: 10.1016/j.ejca.2025.115591.…
Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis
Blood. 2025 Jul 7:blood.2024027197. doi: 10.1182/blood.2024027197.…
Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
Lancet Haematol. 2025 Jul;12(7):e542-e554. doi: 10.1016/S2352-3026(25)00073-0.ABSTRACTAllogeneic…
Correction: Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation
Bone Marrow Transplant. 2025 Jun 30. doi: 10.1038/s41409-025-02664-5.…
Allogeneic haematopoietic cell transplant should still be considered as a curative option for relapsed/refractory large B-cell lymphoma, including in the CAR T-cell era
Br J Haematol. 2025 Jun 25. doi: 10.1111/bjh.20217. Online ahead…
